Ocumension Therapeutics
HKEX:1477.HK
5.41 (HKD) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ocumension Therapeutics |
Symbool | 1477.HK |
Munteenheid | HKD |
Prijs | 5.43 |
Beurswaarde | 4,370,930,085 |
Dividendpercentage | 0% |
52-weken bereik | 4.13 - 7.94 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ye Liu |
Website | https://www.ocumension.com |
An error occurred while fetching data.
Over Ocumension Therapeutics
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)